HHS shifts funding from mRNA vaccines to alternative platforms, raising concerns among health experts about undermining proven technology and pandemic response.
HHS shifts funding from mRNA vaccines to alternative platforms, raising concerns among health experts about undermining proven technology and pandemic response.